CREBBP c.1111G>T ;(p.E371*)

Variant ID: 16-3843492-C-A

NM_004380.2(CREBBP):c.1111G>T;(p.E371*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.

Jid Innovations : Skin Science From Molecules To Population Health
Abdulla, Farah R FR; Zhang, Weiwei W; Wu, Xiwei X; Honda, Kord K; Qin, Hanjun H; Cho, Hyejin H; Querfeld, Christiane C; Zain, Jasmine J; Rosen, Steven Terry ST; Chan, Wing C WC; Parekh, Vishwas V; Song, Joo Y JY
Publication Date: 2022-01

Variant appearance in text: CREBBP: E371X
PubMed Link: 34977845
Variant Present in the following documents:
  • mmc1.xlsx, sheet 1
View BVdb publication page



Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.

Jid Innovations
Abdulla, Farah R FR; Zhang, Weiwei W; Wu, Xiwei X; Honda, Kord K; Qin, Hanjun H; Cho, Hyejin H; Querfeld, Christiane C; Zain, Jasmine J; Rosen, Steven Terry ST; Chan, Wing C WC; Parekh, Vishwas V; Song, Joo Y JY
Publication Date: 2022-01

Variant appearance in text: CREBBP: E371X
PubMed Link: 34977845
Variant Present in the following documents:
  • mmc1.xlsx, sheet 1
View BVdb publication page



Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity.

Cells
Hartman, Mariusz L ML; Sztiller-Sikorska, Malgorzata M; Gajos-Michniewicz, Anna A; Czyz, Malgorzata M
Publication Date: 2020-01-07

Variant appearance in text: CREBBP: E371*
PubMed Link: 31936151
Variant Present in the following documents:
  • cells-09-00142-s001.pdf
View BVdb publication page